Pliant Therapeutics (PLRX) Other Non-Current Liabilities (2019 - 2021)
Pliant Therapeutics (PLRX) posted quarterly Other Non-Current Liabilities of $756000.0 for Q3 2021, down 20.59% year-over-year from $952000.0 in Q3 2020, and down 5.97% quarter-over-quarter from $804000.0 in Q2 2021.
Pliant Therapeutics (PLRX) Other Non-Current Liabilities (2019 - 2021) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Other Non-Current Liabilities for 3 consecutive years, with $756000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Other Non-Current Liabilities fell 20.59% year-over-year to $756000.0; the TTM figure through Sep 2021 stood at $756000.0 (down 20.59% YoY), while the FY2020 annual figure was $866000.0, down 5.04% from the prior year.
- Other Non-Current Liabilities retreated to $756000.0 in Q3 2021 per PLRX's latest filing, from $804000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $952000.0 in Q3 2020 and bottomed at $756000.0 in Q3 2021.
- Historically, Other Non-Current Liabilities has averaged $868000.0 across 3 years, with a median of $866000.0 in 2020.
- Annual changes were most pronounced in 2020 — Other Non-Current Liabilities dropped 5.04% — and 2021, when it retreated 20.59%.
- Pliant Therapeutics' Other Non-Current Liabilities stood at $912000.0 in 2019, then decreased by 5.04% to $866000.0 in 2020, then retreated by 12.7% to $756000.0 in 2021.
- Business Quant data shows PLRX's Other Non-Current Liabilities at $756000.0 in Q3 2021, $804000.0 in Q2 2021, and $835000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pliant Therapeutics | 71.21 Mn | 71.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 756,000.00 |
| Jun 30, 2021 | 804,000.00 |
| Mar 31, 2021 | 835,000.00 |
| Dec 31, 2020 | 866,000.00 |
| Sep 30, 2020 | 952,000.00 |
| Jun 30, 2020 | 951,000.00 |
| Dec 31, 2019 | 912,000.00 |